These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18465074)

  • 21. Analysis of the femoral neck from rats in the periestropause treated with oxytocin and submitted to strength training.
    Fernandes-Breitenbach F; Peres-Ueno MJ; Santos LFG; Brito VGB; Castoldi RC; Louzada MJQ; Chaves-Neto AH; Oliveira SHP; Dornelles RCM
    Bone; 2022 Sep; 162():116452. PubMed ID: 35654351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss.
    Lindberg MK; Svensson J; Venken K; Chavoshi T; Andersson N; Movérare Skrtic S; Isaksson O; Vanderschueren D; Carlsten H; Ohlsson C
    Bone; 2006 Jan; 38(1):85-92. PubMed ID: 16257281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
    Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ
    J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
    Jung K; Lein M; Ringsdorf M; Roigas J; Schnorr D; Loening SA; Staack A
    J Urol; 2006 Oct; 176(4 Pt 1):1326-31. PubMed ID: 16952623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
    Tromp AM; Bravenboer N; Tanck E; Oostlander A; Holzmann PJ; Kostense PJ; Roos JC; Burger EH; Huiskes R; Lips P
    Calcif Tissue Int; 2006 Dec; 79(6):404-15. PubMed ID: 17160577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats.
    Ding Y; Arai M; Kondo H; Togari A
    Bone; 2010 Jun; 46(6):1591-6. PubMed ID: 20193788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I; Balon BP; Rus I; Marc J
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta.
    Bargman R; Posham R; Boskey AL; DiCarlo E; Raggio C; Pleshko N
    Osteoporos Int; 2012 Mar; 23(3):1141-50. PubMed ID: 21901481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide.
    Sahbani K; Cardozo CP; Bauman WA; Tawfeek HA
    Physiol Rep; 2019 Oct; 7(19):e14225. PubMed ID: 31565870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low dose administration of macrophage colony-stimulating factor in mice.
    Yuan Y; Ferguson VL; Simske SJ; Bateman TA
    Biomed Sci Instrum; 2004; 40():93-8. PubMed ID: 15133941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of alendronate administration on bone mineral density and bone strength in castrated rats.
    Broulik PD; Rosenkrancová J; Růzicka P; Sedlácek R
    Horm Metab Res; 2005 Jul; 37(7):414-8. PubMed ID: 16034712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive Oxygen Species Differentially Regulate Bone Turnover in an Age-Specific Manner in Catalase Transgenic Female Mice.
    Alund AW; Mercer KE; Suva LJ; Pulliam CF; Chen JR; Badger TM; Van Remmen H; Ronis MJ
    J Pharmacol Exp Ther; 2016 Jul; 358(1):50-60. PubMed ID: 27189961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice.
    Tsuchiya T; Sakai A; Menuki K; Mori T; Takeuchi Y; Kanoh S; Utsunomiya H; Murai T; Isse T; Kawamoto T; Nakamura T
    Bone; 2013 Apr; 53(2):358-68. PubMed ID: 23313283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.